Characterization of vulvovaginal candidiasis in women in Medellin, Colombia

Caracterización de la candidiasis vulvovaginal en mujeres de la ciudad de Medellín, Colombia

Published 2009-12-31

Open | Download
PDF (Spanish) FLIP HTML (Spanish)
Issue
Vol. 7 No. 12 (2009)
Section
Artículo Original
How to Cite
Duque et al., C. (2009). Characterization of vulvovaginal candidiasis in women in Medellin, Colombia. NOVA, 7(12). https://doi.org/10.22490/24629448.431
DOI

https://doi.org/10.22490/24629448.431
Dimensions
PlumX
license

Licencia Creative Commons

NOVA by http://www.unicolmayor.edu.co/publicaciones/index.php/nova is distributed under a license creative commons non comertial-atribution-withoutderive 4.0 international.

Furthermore, the authors keep their property intellectual rights over the articles.

 

Clara Duque et al.
    Show authors biography
    Vulvovaginal candidiasis affects the vaginal mucosa and is caused by different Candida species. Patients mainly complain of itching and pain. The objective of this research was to characterize the vulvovaginal candidiasis in a group of women with vaginitis. With previous consent, 150 patients with Candida vaginitis were included, between February 2006 and November 2008. A sample of vaginal fluid for direct and  culture was taken. Species identification was confirmed by the API 20 C AUX method, and the sensitivity profile of ATB fungus. The prevalence of different species of Candida was: C. albicans 80% (120), C. parapsilosis 10% (15), C. glabrata 5.3% (8), C. tropicalis 2% (3), C. guillermondii 1.3% (2), C. kefyr 0.7% (1), and Candida famata 0.7% (1).   Of all women, 90% (135 of them) showed symptoms associated with infection by Candida spp; 44.5%, 60 women, showed simultaneous itching and vaginal discharge. 6% of patients had more than 4 episodes of vulvovaginal candidiasis in a year. 90% of Candida albicans isolates were susceptible to fluconazole, itraconazole and voriconazole. 100% of the isolates of C. glabrata susceptible to fluconazole and voriconazole. C. kefyr was intermediate to fluconazole in 100% of the isolates. All other species were 100% susceptible to the antifungals tested. C. albicans was the yeast most frequently recovered, followed by C. parapsilosis and C. glabrata. The general sensitivity to the antifungal is high for all isolates.

    Article visits 278 | PDF visits 157

    Downloads

    Download data is not yet available.
    1. Arango M, Castañeda E. Micosis humanas. 2º edición. Medellín: CIB; 2003.
    2. Díaz FJ, Estrada S, Franco L, Jaramillo JM., Maestre A, Ospina S, et al. Microbiología de las infecciones humanas. 1°. Edición, Medellín: CIB. 2007.
    3. Sobel J, Chaim W. Update on treatment of vulvovaginal candidiasis. Rev Iberoam Micol. 1996;13:44-46.
    4. Rivero M. Frecuencia de especies de Candida aisladas en pacientes embarazadas con vulvovaginitis. Rev Soc Ven de Microbiol. Caracas. 2003;23:148-152.
    5. Buscemi L, Nigrona, R. Estudio de vulvovaginitis agudas en pacientes adultas, sexualmente activas con especial referencia a la candidiasis en pacientes del hospital de infecciosas Francisco J. Muñiz. Rev Iberoam Micol. 2004;21:177-181.
    6. García M, García S, Copolillo E, Cora M, Barata A, Vay C, et al. Prevalencia de candidiasis vaginal en embarazadas. Identificación de levaduras y susceptibilidad a los antifúngicos. Rev. Argentina Microbiol. 2006;38:9-12.
    7. Bauters TG, Dhont MA, Temmerman MI, Nelis HJ. Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women. Am J Obstet. Gynecol. 2002; 187:569-574.
    8. Richter SS, Galask RP, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J Clin Microbiol. 2005;43:2155-2162.
    9. Cuenca-Estrella M, Arendrup MC, Chryssanthou E, Dannaoui E, Lass-Florl C, Sandven P, et al. Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testhing method for fermentative yeasts. Subcommitte of the european committee on antimicrobial susceptibility testing (AFST- EUCAST). Clin Microbiol Infect. 2003;13:1018-1022.
    10. CLSI. Reference method for broth dilution antifungal susceptibility testing of Yeasts. M27-A2. 2002.
    11. Ferrer J. Vaginal candidosis: epidemiological and etiological factors. Int J Gynecol Obstet. 2000;71: S21-7.
    12. Hospenthal DR, Beckius ML, Floyd KL, et al. Presumptive identification of candida species other than C. albicans, C. krusei and C. tropicalis with the CHROMagar candida. Ann Clin Microbiol Antimicrob. 2006;5:1.
    13. Makela PI, Leaman D, Sobel J. Vulvovaginal trichosporonosis. Infect Dis Ostet Gynecol. 2003;11:131-133.
    14. Torres J, Alvarado E. In vitro susceptibilities to yeast using the ATB fungus method, compared with sensitive yeast one and standar CLSI (NCCLS) M27-a2 methods. J Antimic Chemoth. 2007;60:658-661.
    15. Enache-Angoulvant, A. Reglas de interpretación de las infecciones por Candida. Acta bioquím Clín Latinoam. La Plata. 2007;4:587-593.
    16. Buitrón G, Bonifaz A, Amancio O, et al. Correlación clínico-micológica de la candidiasis vulvovaginal. Ginecol Obstet Mex 2007;75:68-72.
    17. -------------------------------------------------------------------------------
    18. DOI: http://dx.doi.org/10.22490/24629448.431
    Tutorials

    Autors:

    How send article?

    Evaluator pair

    How to evaluate an article?

    Information

    Keywords

    Google Scholar profile

    Is part of
     
    Más leídos en los últimos 30 días

    Current Issue

    Sistema OJS 3.4.0.5 - Metabiblioteca |